HEMOCANE Cream 25 Grams
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
06-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
LIDOCAINE HYDROCHLORIDE ZINC OXIDE BISMUTH OXIDE BENZOIC ACID CINNAMIC ACID
Available from:
Eastern Pharmaceuticals Limited
Dosage:
25 Grams
Pharmaceutical form:
Cream
Authorization date:
1995-03-16
Summary of Product characteristics
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Hemocane Cream
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
A smooth white odourless cream intended for external use.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Treatment of the symptoms of haemorrhoids and allied ano-rectal conditions.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults - apply morning and night and after bowel movements until the condition is controlled. Not recommended for
children.
4.3 CONTRAINDICATIONS
Hypersensitivity to any of the ingredients.
Untreated infectious conditions, of bacterial, viral, tuberculous or fungal orgin.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If symptoms persist or worsen, or if an allergic reaction occurs, discontinue use immediately and consult your doctor.
Persons who suffer from haemorrhoids are advised to consult their doctor.
Keep out of reach of children.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None.
4.6 PREGNANCY AND LACTATION
Not to be used in pregnancy unless considered essential by the physician.
Lignocaine Hydrochloride Ph. Eur
0.65 % w/w
Zinc Oxide Ph. Eur
10.00 % w/w
Bismuth Oxide
2.00 % w/w
Cinnamic Acid B.P
0.45 % w/w
Benzoic Acid Ph. Eur
0.40 % w/w
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 13/04/2010_
_CRN 2080946_
_page number: 1_
4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
None.
4.8 UNDESIRABLE EFFECTS
None.
4.9 OVERDOSE
Overdose is unlikely to occur with the cream. Symptoms would be associated with high plasma levels of lignocaine
hydrochloride.
5 PHARMACOLOGICAL PROPERTIES
5.1 PHARMACODYNAMIC PROPERTIES
Lignocaine has local anaesthetic properties. Zinc oxide and bismuth oxide, when applied lo
Read the complete document
